Health Canada has granted approval for medical technology company Clarius Mobile Health’s third-generation product line of high-performance handheld ultrasound scanners.
These scanners can be connected wirelessly to a clinician’s Apple or Android smart device using artificial intelligence (AI)-driven application.
With the latest approval, the pocket-sized scanners are now available across the country with new features.
Scanners from Clarius are currently regarded as a top choice among app-based ultrasound devices, which are used globally for quick bedside diagnosis.
The Clarius HD₃ offers high-definition ultrasound imaging with good usability and price levels.
The complete Clarius HD₃ line of ultra-portable scanners leverages the latest antenna technology for reliable connectivity and works on both iOS and Android devices.
Compared to other handheld devices, the octal beamforming technology offers up to eight times quicker frame rates and micron-level resolution.
Furthermore, new specialised software packages have been created to aid easy usage of Clarius ultrasound for various speciality applications, including Advanced Breast, Aesthetics, Musculoskeletal, Obstetrics, Primary/Critical Care and Vascular packages.
These packages provide devoted presets, improved workflows, complete measurements and fined tuned imaging, using AI and software as a service (SaaS) to offer a comprehensive handheld ultrasound solution.
Last year, the Clarius HD₃ scanners obtained clearance from the US Food and Drug Administration (FDA) and are now offered in various regions globally.
Clarius Mobile Health president Ohad Arazi said: “Our new Clarius HD₃ is no bigger than my iPhone, yet it offers the same high-performance imaging as a traditional ultrasound scanner for a fraction of the cost.
“Plus, we’ve replaced complex knobs and buttons with AI and touch-based controls, so it’s as easy to operate as your smartphone.”